When the campus is complete, it will produce several of Lilly’s APIs and genetic medicines to serve US patients.

More than $21 billion of Lilly’s domestic manufacturing commitments this decade have been directed to Indiana.¹ The Lebanon ...

Strengthens Nokia’s network API product development and go-to-market efforts. Builds on Nokia’s strategy of leading and expanding the network API ecosystem to utilize 5G and 4G network capabilities ...

According to the latest market analysis by Future Market Insights, the global small molecule API market is entering a phase ...

India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...